Washington – Consultant pediatric neurologist Dr. Mohamed Al-Dosari says Cleveland Clinic Hospital will meet the requirements of the U.S. Food and Drug Administration (FDA) by the end of 2023 with an innovative technology for diagnosing autism in children. He said that he plans to adopt a similar method.
Al-Dosari, Ph.D., director of the Pediatric Neuroscience Center at Cleveland Clinic Hospital in Ohio, USA, says this can be done via an eye-tracker without relying on family members or specialist observation. .
In a statement to the Saudi Press Agency (SPA), Dr Al-Dosari said the center worked with several universities and prominent US autism centers to test the device’s accuracy. .
The center is also testing at several centers in the Gulf region, namely the Prince Mohammed bin Salman Center for Autism and Growth Disorders in Riyadh, and the device is patented in the US by the Cleveland Clinic Innovation Center. It points out that it is registered as
This state-of-the-art method will allow autism to be diagnosed earlier, while increasing diagnostic accuracy, reducing costs and maximizing capacity, he added. — Spa